Home › Kidney Failure › Tennessee › Memphis
Kidney Failure clinical trials in Memphis, TN
5 studies for Kidney Failure are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
Recruiting
- James E. Gardner MD, P.C., Memphis
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Lt. Col. Luke Weathers, Jr. VA Medical Center, Memphis
Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
Recruiting
- Memphis VA Medical Center, Memphis, TN, Memphis
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
Recruiting
- Bluff City Vascular, Memphis
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
Recruiting
- James Eric Gardner, MD, PC, Memphis
About Kidney Failure
Healthy kidneys clean your blood by removing excess from your body. But if kidneys are damaged, they won't work properly. Read about the treatments.
More about Kidney Failure on MedlinePlus
Kidney Failure trials in other cities
- Boston, MA12 studies
- Houston, TX11 studies
- Chicago, IL7 studies
- Dallas, TX7 studies
- New York City, NY6 studies
- Orlando, FL6 studies
- Durham, NC5 studies
- Queens, NY5 studies
- Atlanta, GA5 studies
- Phoenix, AZ4 studies
- Seattle, WA4 studies
- Mountain View, CA4 studies
Other studies in Memphis
- Cancer (all types)30 studies
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer21 studies
- Sickle Cell Disease19 studies
- Acute Lymphoblastic Leukemia17 studies
- Lung Cancer17 studies
- Acute Myeloid Leukemia14 studies
- Heart Failure12 studies
- Melanoma11 studies
- Soft Tissue Sarcoma10 studies
- Colorectal Cancer10 studies
- Type 2 Diabetes10 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.